SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 136 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,797,000 | +72.1% | 119,989 | +39.9% | 0.00% | +100.0% |
| Q1 2016 | $1,044,000 | -23.5% | 85,775 | -0.0% | 0.00% | -50.0% |
| Q4 2015 | $1,365,000 | +5.2% | 85,805 | +1.4% | 0.00% | 0.0% |
| Q3 2015 | $1,297,000 | -37.2% | 84,635 | -0.4% | 0.00% | -33.3% |
| Q2 2015 | $2,065,000 | +18.8% | 84,956 | +13.7% | 0.00% | +50.0% |
| Q1 2015 | $1,738,000 | -6.3% | 74,748 | +1.2% | 0.00% | 0.0% |
| Q4 2014 | $1,854,000 | -20.4% | 73,846 | -1.4% | 0.00% | -33.3% |
| Q3 2014 | $2,330,000 | +23.3% | 74,914 | +2.6% | 0.00% | 0.0% |
| Q2 2014 | $1,889,000 | +54.8% | 73,037 | +39.9% | 0.00% | +50.0% |
| Q1 2014 | $1,220,000 | -6.4% | 52,212 | +1.6% | 0.00% | 0.0% |
| Q4 2013 | $1,304,000 | +25.6% | 51,384 | +1.0% | 0.00% | 0.0% |
| Q3 2013 | $1,038,000 | +15.6% | 50,882 | +18.8% | 0.00% | 0.0% |
| Q2 2013 | $898,000 | – | 42,819 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |